Bumper Offer - Urjas oil Just @ Rs. 1 X
Emigo 4 Tablet is a prescription drug, available for use as Tablet. Nausea and Vomiting are some of its major therapeutic uses.
The right dosage of Emigo 4 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Emigo 4 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Emigo 4 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Emigo 4 Tablet's effect during pregnancy is Safe and Mild while nursing. Warnings related to Emigo 4 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Emigo 4 Tablet is contraindicated in people with pre-existing medical conditions like Heart Disease, Calcium Deficiency, Potassium Deficiency as it can result in adverse effects. The section on Emigo 4 Tablet contraindications lists all such conditions.
Drug interactions for Emigo 4 Tablet have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Emigo 4 Tablet is considered not safe while driving, and is not addictive.
Emigo 4 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Emigo 4 Tablet is used -
Moderate
Mild
Is the use of Emigo 4 Tablet safe for pregnant women?
There are no side effects of Emigo in pregnant women.
Is the use of Emigo 4 Tablet safe during breastfeeding?
Emigo has been seen to have minimal side effects on breastfeeding women.
What is the effect of Emigo 4 Tablet on the Kidneys?
Emigo is not harmful for kidneys.
What is the effect of Emigo 4 Tablet on the Liver?
There may be an adverse effect on the liver after taking Emigo. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Emigo 4 Tablet on the Heart?
Emigo can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Emigo 4 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emigo 4 Tablet unless your doctor advises you to do so -
Is this Emigo 4 Tablet habit forming or addictive?
Forming a habit of Emigo 4 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Emigo 4 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Emigo 4 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Emigo 4 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Emigo 4 Tablet
Taking Emigo 4 Tablet with food does not harm your health.
Interaction between Alcohol and Emigo 4 Tablet
Taking alcohol with Emigo 4 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)